FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET

EJNMMI Research

Table 1 Subject baseline characteristics

Subject #	Age (yrs)	Gender	Ethnicity	Positive for CS by HRS criteria?	Cardiac presentation	Biopsy proven extra-cardiac sarcoidosis?	Initial assessment or reassessment?	On active treatment at the time of current imaging?	MRI findings compatible with CS?
1	44	Male	Caucasian	Yes	Bifascicular block	Yes	Reassessment	Yes, methotrexate/prednisone	Yes
2	64	Male	Caucasian	No	Cardiomyopathy	Yes	Initial	No	No
3	49	Male	Caucasian	Yes	Complete AV block	Yes	Initial	No	Yes
4	49	Female	African-American	Yes	Complete AV block	Yes	Initial	No	No
5	57	Male	Caucasian	Yes	Complete AV block	Yes	Reassessment	No	Not performed
6	56	Male	Caucasian	Yes	Cardiomyopathy	Yes	Reassessment	No	Not performed
7	54	Female	Caucasian	No	None	Yes	Initial	No	No
8	66	Male	Caucasian	Yes	Complete AV block	Yes	Reassessment	Yes, methotrexate	Yes
9	68	Male	Caucasian	Yes	None	Yes	Initial	No	Yes
10	57	Male	Caucasian	Yes	Ventricular tachycardia	Yes	Reassessment	Yes, prednisone	Yes
11	54	Female	Caucasian	Yes	Complete AV block	Yes	Initial	No	No
12	57	Male	Caucasian	Yes	Complete AV block	Yes	Initial	No	Yes
13	58	Female	Asian	Yes	Complete AV block	Yes	Initial	No	Yes
14	55	Female	Asian	Yes	Complete AV block	Yes	Initial	No	Not performed